Abstract
Question In cats with osteoarthritis (OA), does the oral supplementation of cannabidiol (CBD) oil, compared to conventional treatment alone, improve treatment outcomes of reducing pain and improving locomotion? Clinical bottom line The category of research question was: Treatment. The number and type of study designs that were critically appraised were: No papers were found relevant to the PICO. Critical appraisal of the selected papers meeting the inclusion criteria collectively provide zero/weak/moderate/strong evidence in terms of their experimental design and implementation: Zero. The outcomes reported are summarised as follows… No studies relevant to the PICO were found (in English) on the use of CBD in cats with OA. In view of the strength of evidence and the outcomes from the studies the following conclusion is made… There is currently no evidence to recommend the use of CBD in cats for the treatment of OA and further studies on therapeutic use of CBD in cats with OA are required.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call